CytRx Investors Seek Cert. In Suit Over Cancer Drug Trial
Investors suing biopharmaceutical company CytRx Corp. for allegedly misrepresenting the success of a late-stage trial of a cancer treatment urged a California federal court Friday to certify a class of investors...To view the full article, register now.
Already a subscriber? Click here to view full article